1 / 3

Catheter Related Bloodstream Infections (CRBSI) Market

Catheter-related bloodstream infection also known as catheter-related sepsis, defined as the presence of bacteremia originating from a catheter insertion. Antibiotics such as antibacterial and antifungal are used for the treatment of the disease. Antibiotic lock therapy is considered as adjunctive therapy in the treatment of CRBSI when catheter removal is not a favorable option. The current treatment options are used as off-label therapies and only a few non-antibiotic lock solutions are approved in Europe. DelveInsightu2019s u2018Catheter-Related Bloodstream Infection (CRBSI) Marketu2019 report delivers an in-depth understanding of the CRBSI historical and forecasted epidemiology, market trends in the geographies listed below.

DelveInsight
Télécharger la présentation

Catheter Related Bloodstream Infections (CRBSI) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Catheter-Related Bloodstream Infection (CRBSI) Market DelveInsight’s ‘Catheter-Related Bloodstream Infection (CRBSI) Market’ report delivers an in-depth understanding of the CRBSI historical and forecasted epidemiology, market trends in the geographies listed below. Geographies Covered: The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan, APAC (China, India, Taiwan, South Korea, and Australia), LATAM (Brazil, Mexico, Argentina, and Colombia), Middle East (Saudi Arabia and the United Arab Emirates) and Russia View full report: https://www.delveinsight.com/report-store/catheter-related- bloodstream-infection-market Catheter-Related Bloodstream Infection: Disease Understanding and Treatment Algorithm Catheter-Related Bloodstream Infection Overview Catheter-related bloodstream infection also known as catheter-related sepsis, defined as the presence of bacteremia originating from a catheter insertion. Antibiotics such as antibacterial and antifungal are used for the treatment of the disease. Antibiotic lock therapy is considered as adjunctive therapy in the treatment

  2. of CRBSI when catheter removal is not a favorable option. The current treatment options are used as off-label therapies and only a few non-antibiotic lock solutions are approved in Europe. CRBSI Diagnosis The diagnosis of catheter-related bloodstream infection remains a major challenge. Fever and chills that are often associated with catheter-related bloodstream infections are not specific. Furthermore, local catheter inflammation and phlebitis could exist in the absence of catheter-related bloodstream infection or even a local infection, as has been reported with peripherally inserted central catheters. CRBSI Treatment It covers the details of conventional and current medical therapies available in the catheter-related bloodstream infection market for the treatment of the condition. It also provides the treatment guidelines and algorithms of the United States and Spain. The DelveInsight’s catheter-related bloodstream infection market report gives a thorough understanding of catheter-related bloodstream infection by including details such as disease definition, causes, risk factors, pathogenesis, and diagnosis. CRBSI Epidemiology The CRBSI epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total incident population of CRBSI total diagnosed incident population of Catheter-Related Bloodstream Infection, and Diagnosed Incidence of Catheter-Related Bloodstream Infection by Causative Pathogens scenario of catheter-related bloodstream infection in the global market. Key Findings This section provides glimpses of the catheter-related bloodstream infection epidemiology in the global market. As per DelveInsight’s analysis, the total incident population of catheter- related bloodstream infection in the global market was found to be 4,114,882 in 2017. The estimates show a higher incidence of catheter- related bloodstream infection in India with 1,722,280 cases in 2017. Download epidemiology insights https://www.delveinsight.com/report-store/catheter-related-bloodstream-infections- crbsis-epidemiology-forecast CRBSI Marketed Drugs of the report:

  3. Neutrolin by CorMedix Taurosept by Geistlich Pharma CRBSI Off-label Drugs Daptomycin Vancomycin CRBSI Emerging Drugs Mino-Lok: Citius Pharmaceuticals Request for our request/catheter-related-bloodstream-infection-market CRBSI Market Outlook The catheter-related bloodstream infection market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted catheter-related bloodstream infection market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers, and demand of better technology. According to DelveInsight, catheter-related bloodstream infection global market is expected to change in the study period 2017–2030. Key Findings This section includes a glimpse of the catheter-related bloodstream infection global market. The market size of CRBSI in the Global market was USD 1,237.38 million in 2017. Download our full report: https://www.delveinsight.com/report-store/catheter- related-bloodstream-infection-market https://www.delveinsight.com/sample- sample report:

More Related